ID   FHL2_HUMAN              Reviewed;         279 AA.
AC   Q14192; Q13229; Q13644; Q2I5I4; Q5TM15; Q9P294;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   10-MAY-2017, entry version 169.
DE   RecName: Full=Four and a half LIM domains protein 2;
DE            Short=FHL-2;
DE   AltName: Full=LIM domain protein DRAL;
DE   AltName: Full=Skeletal muscle LIM-protein 3;
DE            Short=SLIM-3;
GN   Name=FHL2; Synonyms=DRAL, SLIM3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Skeletal muscle;
RX   PubMed=9150430; DOI=10.1089/dna.1997.16.433;
RA   Genini M., Schwalbe P., Scholl F.A., Remppis A., Mattei M.-G.,
RA   Schaefer B.W.;
RT   "Subtractive cloning and characterization of DRAL, a novel LIM-domain
RT   protein down-regulated in rhabdomyosarcoma.";
RL   DNA Cell Biol. 16:433-442(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT MET-167.
RC   TISSUE=Heart;
RX   PubMed=9573400; DOI=10.1016/S0378-1119(97)00644-6;
RA   Chan K.K., Tsui S.K.W., Lee S.M.Y., Luk S.C.W., Liew C.C., Fung K.P.,
RA   Waye M.M.Y., Lee C.Y.;
RT   "Molecular cloning and characterization of FHL2, a novel LIM domain
RT   protein preferentially expressed in human heart.";
RL   Gene 210:345-350(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Leukocyte;
RX   PubMed=11001931; DOI=10.1093/oxfordjournals.hmg.a018919;
RA   Tanahashi H., Tabira T.;
RT   "Alzheimer's disease-associated presenilin 2 interacts with DRAL, an
RT   LIM-domain protein.";
RL   Hum. Mol. Genet. 9:2281-2289(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=15453830; DOI=10.1042/BJ20040775;
RA   Takahashi K., Matsumoto C., Ra C.;
RT   "FHL3 negatively regulates human high-affinity IgE receptor beta-chain
RT   gene expression by acting as a transcriptional co-repressor of MZF-
RT   1.";
RL   Biochem. J. 386:191-200(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT MET-167.
RC   TISSUE=Bone marrow;
RA   Qian Z., Mao L., Fernald A., Yu H., Luo R., Anastasi J., Le Beau M.M.;
RT   "The FHL2 LIM-domain protein is implicated in hematopoiesis and
RT   leukemogenesis.";
RL   Submitted (NOV-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 127-279 (ISOFORM 1), AND VARIANT
RP   MET-167.
RC   TISSUE=Heart muscle;
RX   PubMed=8753811; DOI=10.1006/bbrc.1996.1222;
RA   Morgan M.J., Madgwick A.J.A.;
RT   "Slim defines a novel family of LIM-proteins expressed in skeletal
RT   muscle.";
RL   Biochem. Biophys. Res. Commun. 225:632-638(1996).
RN   [9]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND INTERACTION WITH ZNF638.
RX   PubMed=11813260; DOI=10.1002/jcb.10041.abs;
RA   Ng E.K.O., Chan K.K., Wong C.H., Tsui S.K.W., Ngai S.M., Lee S.M.Y.,
RA   Kotaka M., Lee C.Y., Waye M.M.Y., Fung K.P.;
RT   "Interaction of the heart-specific LIM domain protein, FHL2, with DNA-
RT   binding nuclear protein, hNP220.";
RL   J. Cell. Biochem. 84:556-566(2002).
RN   [10]
RP   INTERACTION WITH TTN.
RX   PubMed=12432079; DOI=10.1242/jcs.00181;
RA   Lange S., Auerbach D., McLoughlin P., Perriard E., Schafer B.W.,
RA   Perriard J.-C., Ehler E.;
RT   "Subcellular targeting of metabolic enzymes to titin in heart muscle
RT   may be mediated by DRAL/FHL-2.";
RL   J. Cell Sci. 115:4925-4936(2002).
RN   [11]
RP   FUNCTION, AND INTERACTION WITH SIRT1 AND FOXO1.
RX   PubMed=15692560; DOI=10.1038/sj.emboj.7600570;
RA   Yang Y., Hou H., Haller E.M., Nicosia S.V., Bai W.;
RT   "Suppression of FOXO1 activity by FHL2 through SIRT1-mediated
RT   deacetylation.";
RL   EMBO J. 24:1021-1032(2005).
RN   [12]
RP   FUNCTION, INTERACTION WITH E4F1, AND SUBCELLULAR LOCATION.
RX   PubMed=16652157; DOI=10.1038/sj.onc.1209567;
RA   Paul C., Lacroix M., Iankova I., Julien E., Schaefer B.W.,
RA   Labalette C., Wei Y., Le Cam A., Le Cam L., Sardet C.;
RT   "The LIM-only protein FHL2 is a negative regulator of E4F1.";
RL   Oncogene 25:5475-5484(2006).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-238, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   FUNCTION, AND INTERACTION WITH GRB7.
RX   PubMed=18853468; DOI=10.1002/jmr.916;
RA   Siamakpour-Reihani S., Argiros H.J., Wilmeth L.J., Haas L.L.,
RA   Peterson T.A., Johnson D.L., Shuster C.B., Lyons B.A.;
RT   "The cell migration protein Grb7 associates with transcriptional
RT   regulator FHL2 in a Grb7 phosphorylation-dependent manner.";
RL   J. Mol. Recognit. 22:9-17(2009).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-78; LYS-167 AND LYS-220, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [17]
RP   STRUCTURE BY NMR OF 98-279.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of LIM domains in LIM-protein 3.";
RL   Submitted (JUN-2006) to the PDB data bank.
CC   -!- FUNCTION: May function as a molecular transmitter linking various
CC       signaling pathways to transcriptional regulation. Negatively
CC       regulates the transcriptional repressor E4F1 and may function in
CC       cell growth. Inhibits the transcriptional activity of FOXO1 and
CC       its apoptotic function by enhancing the interaction of FOXO1 with
CC       SIRT1 and FOXO1 deacetylation. {ECO:0000269|PubMed:15692560,
CC       ECO:0000269|PubMed:16652157, ECO:0000269|PubMed:18853468}.
CC   -!- SUBUNIT: Interacts with ZNF638 and TTN/titin. Interacts with E4F1.
CC       Interacts with GRB7. Interacts with SIRT1 and FOXO1.
CC       {ECO:0000269|PubMed:11813260, ECO:0000269|PubMed:12432079,
CC       ECO:0000269|PubMed:15692560, ECO:0000269|PubMed:16652157,
CC       ECO:0000269|PubMed:18853468}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-701903, EBI-701903;
CC       Q9BRR9:ARHGAP9; NbExp=3; IntAct=EBI-701903, EBI-750254;
CC       P18847:ATF3; NbExp=3; IntAct=EBI-701903, EBI-712767;
CC       Q8N9N5:BANP; NbExp=3; IntAct=EBI-701903, EBI-744695;
CC       Q9H2G9:BLZF1; NbExp=3; IntAct=EBI-701903, EBI-2548012;
CC       P38398:BRCA1; NbExp=6; IntAct=EBI-701903, EBI-349905;
CC       Q53HC0:CCDC92; NbExp=5; IntAct=EBI-701903, EBI-719994;
CC       W5RWE1:CSN2; NbExp=3; IntAct=EBI-701903, EBI-10330381;
CC       Q9NPI6:DCP1A; NbExp=3; IntAct=EBI-701903, EBI-374238;
CC       Q4ZH49:DTX2; NbExp=3; IntAct=EBI-701903, EBI-10192429;
CC       Q86UW9:DTX2; NbExp=3; IntAct=EBI-701903, EBI-740376;
CC       Q9BZQ8:FAM129A; NbExp=3; IntAct=EBI-701903, EBI-6916466;
CC       Q12778:FOXO1; NbExp=8; IntAct=EBI-701903, EBI-1108782;
CC       Q49A26:GLYR1; NbExp=3; IntAct=EBI-701903, EBI-2804292;
CC       Q9UBI6:GNG12; NbExp=4; IntAct=EBI-701903, EBI-358636;
CC       Q0VD86:INCA1; NbExp=3; IntAct=EBI-701903, EBI-6509505;
CC       P14923:JUP; NbExp=3; IntAct=EBI-701903, EBI-702484;
CC       Q63ZY3:KANK2; NbExp=3; IntAct=EBI-701903, EBI-2556193;
CC       Q5T5P2-6:KIAA1217; NbExp=3; IntAct=EBI-701903, EBI-10188326;
CC       Q16656:NRF1; NbExp=3; IntAct=EBI-701903, EBI-2547810;
CC       Q9Y5P3:RAI2; NbExp=3; IntAct=EBI-701903, EBI-746228;
CC       Q04864:REL; NbExp=3; IntAct=EBI-701903, EBI-307352;
CC       P48380:RFX3; NbExp=4; IntAct=EBI-701903, EBI-742557;
CC       Q8IYX7:SAXO1; NbExp=3; IntAct=EBI-701903, EBI-3957636;
CC       O43699:SIGLEC6; NbExp=3; IntAct=EBI-701903, EBI-2814604;
CC       Q96EB6:SIRT1; NbExp=2; IntAct=EBI-701903, EBI-1802965;
CC       Q02086:SP2; NbExp=3; IntAct=EBI-701903, EBI-8651703;
CC       Q9NYA1:SPHK1; NbExp=7; IntAct=EBI-701903, EBI-985303;
CC       Q9NPA5:ZFP64; NbExp=3; IntAct=EBI-701903, EBI-711679;
CC       Q9NTW7:ZFP64; NbExp=3; IntAct=EBI-701903, EBI-745730;
CC       Q5VZL5:ZMYM4; NbExp=3; IntAct=EBI-701903, EBI-2514659;
CC       P52739-2:ZNF131; NbExp=3; IntAct=EBI-701903, EBI-10213055;
CC       Q9H9D4:ZNF408; NbExp=3; IntAct=EBI-701903, EBI-347633;
CC       Q8TAU3:ZNF417; NbExp=3; IntAct=EBI-701903, EBI-740727;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q14192-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q14192-2; Sequence=VSP_056999, VSP_057000;
CC   -!- TISSUE SPECIFICITY: Expressed in skeletal muscle and heart.
CC       {ECO:0000269|PubMed:11813260}.
CC   -!- DOMAIN: The third LIM zinc-binding mediates interaction with E4F1.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/FHL2ID44092ch2q12.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L42176; AAA85333.1; -; mRNA.
DR   EMBL; U29332; AAC52073.1; -; mRNA.
DR   EMBL; AB038794; BAA92253.1; -; Genomic_DNA.
DR   EMBL; AB158503; BAD69710.1; -; mRNA.
DR   EMBL; DQ307067; ABC25549.1; -; mRNA.
DR   EMBL; AC012360; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC068273; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC108058; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC014397; AAH14397.1; -; mRNA.
DR   EMBL; U60117; AAC50794.1; -; mRNA.
DR   CCDS; CCDS2070.1; -. [Q14192-1]
DR   PIR; JC6565; JC6565.
DR   RefSeq; NP_001034581.1; NM_001039492.2. [Q14192-1]
DR   RefSeq; NP_001305823.1; NM_001318894.1. [Q14192-1]
DR   RefSeq; NP_001305824.1; NM_001318895.1. [Q14192-1]
DR   RefSeq; NP_001305825.1; NM_001318896.1. [Q14192-1]
DR   RefSeq; NP_001305826.1; NM_001318897.1.
DR   RefSeq; NP_001441.4; NM_001450.3. [Q14192-1]
DR   RefSeq; NP_963849.1; NM_201555.1. [Q14192-1]
DR   RefSeq; NP_963851.2; NM_201557.3. [Q14192-1]
DR   RefSeq; XP_011509100.1; XM_011510798.2. [Q14192-1]
DR   UniGene; Hs.443687; -.
DR   PDB; 1X4K; NMR; -; A=101-159.
DR   PDB; 1X4L; NMR; -; A=221-279.
DR   PDB; 2D8Z; NMR; -; A=162-218.
DR   PDB; 2MIU; NMR; -; A=1-98.
DR   PDBsum; 1X4K; -.
DR   PDBsum; 1X4L; -.
DR   PDBsum; 2D8Z; -.
DR   PDBsum; 2MIU; -.
DR   ProteinModelPortal; Q14192; -.
DR   SMR; Q14192; -.
DR   BioGrid; 108565; 134.
DR   DIP; DIP-5980N; -.
DR   IntAct; Q14192; 100.
DR   MINT; MINT-120725; -.
DR   STRING; 9606.ENSP00000322909; -.
DR   iPTMnet; Q14192; -.
DR   PhosphoSitePlus; Q14192; -.
DR   SwissPalm; Q14192; -.
DR   BioMuta; FHL2; -.
DR   DMDM; 116241364; -.
DR   UCD-2DPAGE; Q14192; -.
DR   EPD; Q14192; -.
DR   PaxDb; Q14192; -.
DR   PeptideAtlas; Q14192; -.
DR   PRIDE; Q14192; -.
DR   DNASU; 2274; -.
DR   Ensembl; ENST00000322142; ENSP00000322909; ENSG00000115641. [Q14192-1]
DR   Ensembl; ENST00000358129; ENSP00000350846; ENSG00000115641. [Q14192-2]
DR   Ensembl; ENST00000393352; ENSP00000377020; ENSG00000115641. [Q14192-1]
DR   Ensembl; ENST00000393353; ENSP00000377021; ENSG00000115641. [Q14192-1]
DR   Ensembl; ENST00000408995; ENSP00000386633; ENSG00000115641. [Q14192-1]
DR   Ensembl; ENST00000409807; ENSP00000386665; ENSG00000115641. [Q14192-1]
DR   GeneID; 2274; -.
DR   KEGG; hsa:2274; -.
DR   UCSC; uc061mpc.1; human. [Q14192-1]
DR   CTD; 2274; -.
DR   DisGeNET; 2274; -.
DR   GeneCards; FHL2; -.
DR   HGNC; HGNC:3703; FHL2.
DR   HPA; CAB008368; -.
DR   HPA; HPA005922; -.
DR   HPA; HPA006028; -.
DR   MalaCards; FHL2; -.
DR   MIM; 602633; gene.
DR   neXtProt; NX_Q14192; -.
DR   OpenTargets; ENSG00000115641; -.
DR   Orphanet; 154; Familial isolated dilated cardiomyopathy.
DR   PharmGKB; PA164; -.
DR   eggNOG; ENOG410KCU4; Eukaryota.
DR   eggNOG; ENOG410XRFY; LUCA.
DR   GeneTree; ENSGT00760000118910; -.
DR   HOGENOM; HOG000231075; -.
DR   HOVERGEN; HBG074526; -.
DR   InParanoid; Q14192; -.
DR   KO; K14380; -.
DR   PhylomeDB; Q14192; -.
DR   TreeFam; TF321684; -.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   SIGNOR; Q14192; -.
DR   ChiTaRS; FHL2; human.
DR   EvolutionaryTrace; Q14192; -.
DR   GeneWiki; FHL2; -.
DR   GenomeRNAi; 2274; -.
DR   PRO; PR:Q14192; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000115641; -.
DR   CleanEx; HS_FHL2; -.
DR   ExpressionAtlas; Q14192; baseline and differential.
DR   Genevisible; Q14192; HS.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0031430; C:M band; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0030018; C:Z disc; IEA:Ensembl.
DR   GO; GO:0050681; F:androgen receptor binding; NAS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0003713; F:transcription coactivator activity; NAS:UniProtKB.
DR   GO; GO:0008134; F:transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0030521; P:androgen receptor signaling pathway; NAS:UniProtKB.
DR   GO; GO:0055014; P:atrial cardiac muscle cell development; IEA:Ensembl.
DR   GO; GO:0060347; P:heart trabecula formation; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:0001649; P:osteoblast differentiation; IEA:Ensembl.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   GO; GO:0009725; P:response to hormone; IMP:BHF-UCL.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0055015; P:ventricular cardiac muscle cell development; IEA:Ensembl.
DR   InterPro; IPR001781; Znf_LIM.
DR   Pfam; PF00412; LIM; 4.
DR   SMART; SM00132; LIM; 4.
DR   PROSITE; PS00478; LIM_DOMAIN_1; 4.
DR   PROSITE; PS50023; LIM_DOMAIN_2; 4.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Isopeptide bond; LIM domain; Metal-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat; Transcription;
KW   Transcription regulation; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN         1    279       Four and a half LIM domains protein 2.
FT                                /FTId=PRO_0000075737.
FT   DOMAIN       40     92       LIM zinc-binding 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   DOMAIN      101    153       LIM zinc-binding 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   DOMAIN      162    212       LIM zinc-binding 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   DOMAIN      221    275       LIM zinc-binding 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   ZN_FING       7     31       C4-type. {ECO:0000255}.
FT   MOD_RES     238    238       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   CROSSLNK     78     78       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447}.
FT   CROSSLNK    167    167       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447}.
FT   CROSSLNK    220    220       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447}.
FT   VAR_SEQ      53    151       DLSYKDRHWHEACFHCSQCRNSLVDKPFAAKEDQLLCTDCY
FT                                SNEYSSKCQECKKTIMPGTRKMEYKGSSWHETCFICHRCQQ
FT                                PIGTKSFIPKDNQNFCV -> VPARWSTRAAAGMRPASSAT
FT                                AASSQLEPRVSSPKTIRISVCPAMRNNMPCSAFSAKSPSPR
FT                                EGSLTGSSPGTRSASCAPPAGSSCLGSASQLAMTLPTA
FT                                (in isoform 2).
FT                                {ECO:0000303|PubMed:15453830}.
FT                                /FTId=VSP_056999.
FT   VAR_SEQ     152    279       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15453830}.
FT                                /FTId=VSP_057000.
FT   VARIANT     167    167       K -> M (in dbSNP:rs1127588).
FT                                {ECO:0000269|PubMed:8753811,
FT                                ECO:0000269|PubMed:9573400,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_067455.
FT   TURN          8     10       {ECO:0000244|PDB:2MIU}.
FT   STRAND       20     22       {ECO:0000244|PDB:2MIU}.
FT   STRAND       25     27       {ECO:0000244|PDB:2MIU}.
FT   HELIX        29     36       {ECO:0000244|PDB:2MIU}.
FT   TURN         41     43       {ECO:0000244|PDB:2MIU}.
FT   STRAND       45     47       {ECO:0000244|PDB:2MIU}.
FT   STRAND       53     56       {ECO:0000244|PDB:2MIU}.
FT   STRAND       59     62       {ECO:0000244|PDB:2MIU}.
FT   TURN         63     65       {ECO:0000244|PDB:2MIU}.
FT   TURN         69     71       {ECO:0000244|PDB:2MIU}.
FT   STRAND       76     78       {ECO:0000244|PDB:2MIU}.
FT   HELIX        90     97       {ECO:0000244|PDB:2MIU}.
FT   STRAND      101    104       {ECO:0000244|PDB:1X4K}.
FT   STRAND      110    112       {ECO:0000244|PDB:1X4K}.
FT   STRAND      114    117       {ECO:0000244|PDB:1X4K}.
FT   STRAND      120    123       {ECO:0000244|PDB:1X4K}.
FT   TURN        124    127       {ECO:0000244|PDB:1X4K}.
FT   STRAND      130    132       {ECO:0000244|PDB:1X4K}.
FT   STRAND      138    144       {ECO:0000244|PDB:1X4K}.
FT   STRAND      147    150       {ECO:0000244|PDB:1X4K}.
FT   HELIX       151    157       {ECO:0000244|PDB:1X4K}.
FT   STRAND      163    165       {ECO:0000244|PDB:2D8Z}.
FT   STRAND      171    182       {ECO:0000244|PDB:2D8Z}.
FT   TURN        183    185       {ECO:0000244|PDB:2D8Z}.
FT   STRAND      189    191       {ECO:0000244|PDB:2D8Z}.
FT   STRAND      201    208       {ECO:0000244|PDB:2D8Z}.
FT   HELIX       210    216       {ECO:0000244|PDB:2D8Z}.
FT   TURN        222    225       {ECO:0000244|PDB:1X4L}.
FT   STRAND      231    233       {ECO:0000244|PDB:1X4L}.
FT   TURN        246    248       {ECO:0000244|PDB:1X4L}.
FT   STRAND      252    254       {ECO:0000244|PDB:1X4L}.
FT   STRAND      267    271       {ECO:0000244|PDB:1X4L}.
FT   HELIX       273    277       {ECO:0000244|PDB:1X4L}.
SQ   SEQUENCE   279 AA;  32193 MW;  E94E3A7F6601F9F3 CRC64;
     MTERFDCHHC NESLFGKKYI LREESPYCVV CFETLFANTC EECGKPIGCD CKDLSYKDRH
     WHEACFHCSQ CRNSLVDKPF AAKEDQLLCT DCYSNEYSSK CQECKKTIMP GTRKMEYKGS
     SWHETCFICH RCQQPIGTKS FIPKDNQNFC VPCYEKQHAM QCVQCKKPIT TGGVTYREQP
     WHKECFVCTA CRKQLSGQRF TARDDFAYCL NCFCDLYAKK CAGCTNPISG LGGTKYISFE
     ERQWHNDCFN CKKCSLSLVG RGFLTERDDI LCPDCGKDI
//
